Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of A/H1N1 Pandemic Vaccine Formulations
NCT00953524Phase 2Completed
- Sponsor
- Sanofi
- Start
- Aug 2009
- Primary completion
- Mar 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of monovalent subvirion a/h1n1 influenza vaccine in influenza A H1N1 infection (H1N1), sponsored by Sanofi. Started Aug 2009; status: completed.
02
Drugs
monovalent subvirion a/h1n1 influenza vaccine
03
Conditions
influenza A H1N1 infection (H1N1)
Beyond the preview
Go deeper on NCT00953524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00953524.